Cargando…

Cessation or dose reduction of Capecitabine due to Complications in Patients with Colon Cancer

Detalles Bibliográficos
Autor principal:	Sohn, Seung Kook
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Coloproctology 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998012/ https://www.ncbi.nlm.nih.gov/pubmed/21152223 http://dx.doi.org/10.3393/jksc.2010.26.4.240

Ejemplares similares

Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
por: Yun, Jung-A, et al.
Publicado: (2010)

Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
por: Baird, R, et al.
Publicado: (2011)

Capecitabine for primary breast cancer
por: Toi, Masakazu, et al.
Publicado: (2017)

Use of capecitabine in management of early colon cancer
por: Hameed, H, et al.
Publicado: (2011)

Clinical Management of Localized Colon Cancer with Capecitabine
por: Quidde, J., et al.
Publicado: (2012)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2009)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2008)

Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer
por: Miger, Jasmine, et al.
Publicado: (2014)

Smoking Cessation in Cancer Survivors
por: Cho, Young Gyu
Publicado: (2021)

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Smoking Cessation for Hospital Patients: An Opportunity to Increase the Reach of Effective Smoking Cessation Programs
por: Bastian, Lori A.
Publicado: (2008)

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
por: Matevska-Geshkovska, Nadica, et al.
Publicado: (2018)

Incidentally Discovered Aortic Thrombosis in a Patient Undergoing Capecitabine and Oxaliplatin Chemotherapy for Colon Cancer
por: Burton, Kyle A, et al.
Publicado: (2023)

A Case of Capecitabine-Induced Sarcoidosis
por: Kang, Shin Myung, et al.
Publicado: (2012)

Compound Capecitabine Colon-Targeted Microparticle Prepared by Coaxial Electrospray for Treatment of Colon Tumors
por: Chen, Ruiqi, et al.
Publicado: (2022)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

The Current Status and Challenges of National Smoking Cessation Support Program in Korea
por: Oh, Seung-Won
Publicado: (2019)

Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)

The SNPs in pre-miRNA are related to the response of capecitabine-based therapy in advanced colon cancer patients
por: Mao, Yong, et al.
Publicado: (2017)

Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts
por: Thuss-Patience, P C, et al.
Publicado: (2011)

Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients
por: Breithaupt, Andrew D., et al.
Publicado: (2015)

Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine
por: Tognetti, Linda, et al.
Publicado: (2015)

Light Dosing and Tissue Penetration: It Is Complicated
por: Lanzafame, Raymond
Publicado: (2020)

Capecitabine in the management of colorectal cancer
por: Hirsch, Bradford R, et al.
Publicado: (2011)

Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine
por: Cohen, Philip R
Publicado: (2017)

Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study
por: Lee, Soo Jung, et al.
Publicado: (2009)

Survival Benefits of Smoking Cessation After Breast Cancer Diagnosis
por: Passarelli, Michael N., et al.
Publicado: (2017)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
por: Peng, Jingyuan, et al.
Publicado: (2018)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021)

Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma
por: Pons-Tostivint, Elvire
Publicado: (2023)

＜Editors’ Choice＞ Clinical impact of standardized creatinine on dose adjustment of capecitabine
por: Ito, Ayaka, et al.
Publicado: (2022)

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours
por: Siegel-Lakhai, W S, et al.
Publicado: (2008)

Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
por: Brickell, K, et al.
Publicado: (2003)

Generalised Lichenoid Drug Eruption Accompanied by Hand-foot Syndrome Due to Capecitabine
por: Tamer, Funda, et al.
Publicado: (2018)

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
por: Lesterhuis, W J, et al.
Publicado: (2010)

Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin
por: Ameli, Hossein, et al.
Publicado: (2022)

Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer
por: Jiménez-Alonso, Julio José, et al.
Publicado: (2022)

Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data
por: Amlani, Adam, et al.
Publicado: (2016)

The reduction of tuberculosis risks by smoking cessation
por: Wen, Chi-Pang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7bn66vfbb1ivocoqmjn5i8vqsd